Newsroom

The latest news and updates on Sooma tDCS™, neurostimulation treatment, and what’s happening at Sooma Medical.

Clinician instruction patient during first Sooma Treatment

September 19, 2024 / News

Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare

August 19, 2024 / News

Prioritizing Youth Mental Health: A Call to Action

March 12, 2024 / News

Sooma Secures €5M Funding for At-home Brain Stimulation Therapies

February 6, 2024 / News

Release Notes for Sooma Duo App and Portal Software Version 1.2.3

December 20, 2023 / News

Reflecting on a Year of Innovation and Achievement: Sooma in 2023

A nurse trains a patient in the use of Sooma Duo, so they can self-administer the therapy at home

October 26, 2023 / News

Sooma launches system for remote clinician-monitored brain stimulation

A man sitting in a porch wearing Sooma tDCS cap

September 15, 2023 / News

Sooma becomes the first tDCS device manufacturer to receive European MDR certification

June 14, 2023 / News

Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment

Image showing the schematic description of Sooma's electrode placement on the patent documentation, laying side-by-side with a 3D model of the actual product once developed

June 8, 2023 / News

Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio

Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio

March 6, 2023 / News

FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device

December 8, 2022 / News

New European Regulation reclassifies brain stimulation equipment without an intended medical purpose as class III

December 7, 2022 / News

Sooma’s latest study provides the largest dataset to date on the effects of tDCS for treating MDD in real-world clinical practice